ZA884239B - Leukotriene antagonists - Google Patents

Leukotriene antagonists

Info

Publication number
ZA884239B
ZA884239B ZA884239A ZA884239A ZA884239B ZA 884239 B ZA884239 B ZA 884239B ZA 884239 A ZA884239 A ZA 884239A ZA 884239 A ZA884239 A ZA 884239A ZA 884239 B ZA884239 B ZA 884239B
Authority
ZA
South Africa
Prior art keywords
alkyl
alkoxy
leukotriene antagonists
cor3
furanyl
Prior art date
Application number
ZA884239A
Other languages
English (en)
Inventor
John Gerald Gleason
Gerald Gleason John
Ralph Floyd Hall
Floyd Hall Ralph
Irene Nijole Uzinskas
Nijole Uzinskas Irene
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZA884239B publication Critical patent/ZA884239B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA884239A 1987-06-24 1988-06-14 Leukotriene antagonists ZA884239B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6659287A 1987-06-24 1987-06-24

Publications (1)

Publication Number Publication Date
ZA884239B true ZA884239B (en) 1989-06-28

Family

ID=22070480

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA884239A ZA884239B (en) 1987-06-24 1988-06-14 Leukotriene antagonists

Country Status (11)

Country Link
US (1) US5135938A (fr)
EP (1) EP0296731B1 (fr)
JP (1) JP2677382B2 (fr)
AT (1) ATE79873T1 (fr)
AU (1) AU1759488A (fr)
DE (1) DE3874021T2 (fr)
DK (1) DK327188A (fr)
ES (1) ES2051850T3 (fr)
GR (1) GR3006224T3 (fr)
PT (1) PT87616B (fr)
ZA (1) ZA884239B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254571A (en) * 1988-04-21 1993-10-19 Smith Kline & French Laboratories Ltd. Chemical compounds
CA2083610A1 (fr) * 1990-06-06 1991-12-07 John G. Gleason Antagonistes de la leucotriene
CN110770272B (zh) * 2017-06-19 2022-03-29 Sika技术股份公司 潜在固化剂和可固化的聚氨酯组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868369A (en) 1972-11-14 1975-02-25 Smithkline Corp 3-heterocyclicthiomethylcephalosporins
US4286089A (en) 1974-12-27 1981-08-25 Smithkline Corporation 7-Acyl-3-(substituted tetrazolyl thiomethyl)cephalosporins
US3989694A (en) 1974-12-27 1976-11-02 Smithkline Corporation 7-Acyl-3-(substituted triazolyl thiomethyl)cephalosporins
US4048311A (en) 1976-01-08 1977-09-13 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl)cephalosporins
US4220644A (en) 1976-05-03 1980-09-02 Smithkline Corporation 7-Acylamino-3-(substituted tetrazolyl thiomethyl) cephalosporins
IL69691A (en) * 1982-09-23 1988-01-31 Merck Frosst Canada Inc Leukotriene antagonists,their preparation and pharmaceutical compositions containing them
US4661505A (en) * 1982-11-03 1987-04-28 Eli Lilly And Company Leukotriene antagonists
JPS59161366A (ja) * 1983-03-04 1984-09-12 Zenichi Yoshida チアジアゾリノン類
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
IL72385A (en) * 1983-07-18 1988-03-31 Lilly Co Eli Leukotriene antagonistic tetrasubstituted benzene derivatives,their preparation and pharmaceutical preparations containing them
GB8320943D0 (en) * 1983-08-03 1983-09-07 Lilly Industries Ltd Organic compounds
GB8432144D0 (en) * 1984-12-20 1985-01-30 Lilly Industries Ltd Organic compounds
GB8502258D0 (en) * 1985-01-30 1985-02-27 Lilly Industries Ltd Organic compounds
EP0217519B1 (fr) * 1985-08-31 1992-02-05 FISONS plc Inhibiteurs de l'enzyme de conversion de l'angiotensine hétérocycliques à 5 chaînons
GB8530222D0 (en) * 1985-12-07 1986-01-15 Lilly Industries Ltd Organic compounds

Also Published As

Publication number Publication date
JP2677382B2 (ja) 1997-11-17
ES2051850T3 (es) 1994-07-01
DE3874021D1 (de) 1992-10-01
GR3006224T3 (fr) 1993-06-21
ATE79873T1 (de) 1992-09-15
EP0296731A1 (fr) 1988-12-28
AU1759488A (en) 1989-01-05
EP0296731B1 (fr) 1992-08-26
US5135938A (en) 1992-08-04
DK327188D0 (da) 1988-06-15
PT87616A (pt) 1988-06-01
DE3874021T2 (de) 1993-02-11
JPS6426571A (en) 1989-01-27
PT87616B (pt) 1992-09-30
DK327188A (da) 1988-12-25

Similar Documents

Publication Publication Date Title
HUP9802578A2 (hu) Fenil-ecetsav-származékok, eljárás és intermedierek előállításukhoz, a vegyületeket hatóanyagként tartalmazó fungicid, inszekticid, arachnicid és nematocid készítmények és alkalmazásuk
DK633088D0 (da) Hidtil ukendte forbindelser
ES480850A1 (es) Procedimiento para preparar hidantoinas.
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
ATE68176T1 (de) Leukotrienantagonisten.
ZA884239B (en) Leukotriene antagonists
DK663588D0 (da) Hidtil ukendte forbindelser
EP0239064A3 (fr) Composés herbicides, leur préparation et utilisation
ES2063271T3 (es) Antagonistas de leucotrienos.
DE3783279D1 (de) Substituierte furazane.
YU134591A (sh) Postupak i intermedijer za dobijanje 2-hidroksi-3-sulfido-3- fenilpropionske kiseline
ES8506606A1 (es) Procedimiento de preparacion de eteres oximas basicos y de sus sales de adicion acidas
DE69014239D1 (de) Phenylglycidamide, verwendbar in der Herstellung von alpha-Hydroxy-beta-sulfido-arylpropionsäure-Derivaten.
EP0293839A3 (fr) Dérivé de phényl (ou pyridyl) urée substituée et composition herbicide le contenant comme ingrédient actif
JPS53127444A (en) Oxime substd. phenylacetic acid derivtives and their preparation
JPS5798243A (en) Preparation of 5-(n-methylaminoethoxy)carvacrol
TH3017EX (th) 2-เฟนิล-4,5,6,7-เททราไฮโดร-2h-อินดาโซลและวิธีผลิตและประโยชน์ของสารเหล่านี้